The genetic basis of high-altitude pulmonary oedema

Pharmacology and Therapeutics

Volumn 101, Issue 2, 2004, Pages 183-192

  Mortimer, Heather ^a   Patel, Sam ^a   Peacock, Andrew J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

ACE gene; Aetiology; Genetic polymorphisms; HIF; High altitude pulmonary oedema; Mediator molecules

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; OXYGEN; RENIN; SALMETEROL; SEROTONIN TRANSPORTER; SODIUM; TYROSINE 3 MONOOXYGENASE;

ADAPTATION; ALTITUDE DISEASE; DISEASE PREDISPOSITION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; INFLAMMATION; LUNG EDEMA; LUNG LAVAGE; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; RECURRENCE RISK; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM TRANSPORT;

EID: 0842309205     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2003.11.003     Document Type: Review

References (93)

1. Acker H. Cellular oxygen sensors. Ann NY Acad Sci. 718:1994;3-10.
2. Aldashev A.A., Sarybaev A.S., Sydykov A.S., Kalmyrzaev B.B., Kim E.V., Mamanova L.B., Maripov R., Kojonazarov B.K., Mirrakhimov M.M., Wilkins M.R., Morrell N.W. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med. 166(10):2002;1396-1402.
3. Allen A.M. Angiotensin AT 1 receptor mediated excitation of rat carotid body chemoreceptor afferent activity. J Physiol (Lond). 510(3):1998;773-781.
4. Archer S.L., Will J.A., Weir E.K. Redox status in the control on pulmonary vascular tone. Hertz. 11(3):1986;127-141.
5. Bartsch P., Shaw S., Franciolli M., Gnadinger M.P., Weidmann P. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol. 65(5):1988;1929-1937.
6. Bartsch P., Maggiorini M., Schobersberger W., Shaw S., Rascher W., Girard J., Weidemann P., Oelz O. Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol. 71:1991;136-143.
7. Bartsch P., Haefeli W.E., Gasse C. Lack of association of high altitude pulmonary edema and polymorphisms on the NO pathway. High Alt Med Biol. 3:2002;105. (abstract).
8. Basnyat B., Murdoch D.R. High altitude illness. Lancet. 361(9373):2003;1967-1974.
9. Beck I., Ramirez S., Weinmann R., Caro J. Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem. 266(24):1991;15563-15566.
10. Bisgard G.E. Carotid body mechanisms in acclimatization to hypoxia. Respir Physiol. 121(2-3):2000;237-246.
11. Blancher C., Moore J.W., Talks K.L., Houlbrook S., Harris A.L. Relationship of hypoxia-inducible factor (HIF-1)-alpha and HIH-2 alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res. 60(24):2000;7106-7113.
12. Blitzer M.L., Loh E., Roddy M., Stamler J.S., Creager M.A. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol. 28(3):1996;591-596.
13. Burki N.K. Effects of acute exposure to high altitude on ventilatory drive and respiratory pattern. J Appl Physiol. 56(4):1984;1027-1031.
14. Cargill R.I., Lipworth B.J. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest. 109(2):1996;424-429.
15. Chandel N.S., Schumacker P.T. Cellular oxygen sensing by mitochondria: old questions new insights. J Appl Physiol. 88(5):2000;1880-1889.
16. Colice G.L., Ramirez G. Effect of hypoxaemia on the renin-angiotensin- aldosterone system in humans. J Appl Physiol. 58(3):1985;724-730.
17. Collins D.D., Scoggin C.H., Zwillich C.W., Weil J.V. Hereditary aspects of decreased hypoxic response. J Clin Invest. 62:1978;105-110.
18. Crudden N.M.L., Newby D.E., Ross J.A., Johnston N.R., Webb D.J. Effect of cold exposure, exercise and high altitude on plasma endothlin-1 and endothelial cell markers in man. Scott Med J. 44:1999;143-146.
19. Czyzyk-Krzeska M.F. Molecular aspects of oxygen sensing in physiological adaptation to hypoxia. Respir Physiol. 110(2-3):1997;99-111.
20. Danser A.H.J., Schalekamp M.A.D.H., Bax W.A., Brink A.M.v.d., Saxena P.R., Riegger G.A.J., Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 92(6):1995;1387-1388.
21. Dehnert C., Weymann J., Montgomery H.E., Woods D., Maggiorini M., Scherrer U., Gibbs J.S., Bartsch P. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc. 34(12):2002;1928-1933.
22. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizumi T., Fujimoto K., Kobayashi T., Kubo K. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:2002;826-830.
23. Duplain H., Sartori C., Lepori M., Egli M., Yves A., Nicod P., Scherrer U. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med. 162:2000;221-224.
24. Fagan K.A., Fouty B.W., Tyler R.C., Morris K.G., Hepler L.K., Sato K., Cras T.D.L., Abman S.H., Weinberger H.D., Huang P.L., McMurtry I.F., Rodman D.M. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest. 103:1999;291-299.
25. Fandrey J., Frede S., Ehleben W., Porwol T., Acker H., Jelkmann W. Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoetin production by reactive oxygen species. Kidney Int. 51:1997;492-496.
26. Firth J.D., Ebert B.L., Ratcliff P.J. Hypoxic regulation of lactate dehydrogenase: interaction between hypoxia inducible factor 1 and cAMP response elements. J Biol Chem. 270(36):1995;21021-21027.
27. Frostell C., Fratacci M., Wain J.C., Jones R., Zapol W.M. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 83(4):1991;2038-2047.
28. Gayagay G., Yu B., Hambly B., Boston T., Hahn A., Celermajer D.S., Trent R.J. Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum Genet. 103:1998;48-50.
29. Goerre S., Wenk M., Bartsch P., Luscher T.F., Niroomand F., Hohenhaus E., Oelz O., Reinhart W.H. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation. 91(2):1995;359-364.
30. Goldberg M.A., Dunning S.P., Bunn H.F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science. 242:1988;1412-1415.
31. Hackett P.H., Roach R.C., Schoene R.B., Harrison G.L., Mills W.J. Abnormal control of ventilation in high-altitude pulmonary oedema. J Appl Physiol. 64(3):1988;1268-1272.
32. Hanaoka M., Droma Y., Hotta J., Matsuzawa Y., Kobayashi T., Kubo K., Ota M. Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest. 123:2003;54-58.
33. Hassoun P.M., Thappa B., Landman M.J., Fanburg B.L. Endothlin-1 mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 199:1992;165-170.
34. Horiguchi H., Bunn H.F. Erythropoetin induction in Hep3B cells is not affected by inhibition on heme biosynthesis. Biochim Biophys Acta. 1495:2000;231-236.
35. Hultgren H.N., Marticorena E.A. High altitude pulmonary oedema: epidemiological observations in Peru. Chest. 74(4):1978;372-376.
36. Hultgren H.N., Robinson M.C., Wuerflein R.D. Over perfusion pulmonary edema. Circulation. 34(Suppl 3):1966;132-133.
37. Hultgren H.N., Grover R.F., Hartley L.H. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation. 44:1971;759-770.
38. Hummler E., Barker P., Gatzy J., Beerman F., Verdumo C., Schmidt A., Rossier B.C. Early death due to defective neonatal lung liquid clearance in alpha ENaC-deficient mice. Nat Genet. 12:1996;325-328.
39. Hummler E., Barker P., Talbot C., Wang Q., Verdumo C., Grubb B., Gatzy J., Burnier M., Horisberger J.D., Beermann F., Boucher R., Rossier B.C. A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci USA. 94:1997;11710-11715.
40. Jackson R.M., Narkates A.J., Oparil S. Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia. J Appl Physiol. 60:1986;1121-1127.
41. Janakidevi K., Fisher M.A., Vecchio P.J.D., Tiruppathi C., Figge J., Malik A.B. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol. 263:1992;C1295-C1301.
42. Jewell U.R., Kveitikova I., Scheid A., Bauer C., Wenger R.H., Gassmann M. Induction of HIF-1 alpha in response to hypoxia in instantaneous. FASEB J. 15(7):2001;1312-1314.
43. Kawakami Y., Irie T., Kishi Y., Asanuma Y., Shida A., Yoshikawa T., Kamishima K., Hasegan H., Murao M. Familial aggregation of abnormal ventilatory control and pulmonary function in chronic obstructive pulmonary disease. Eur J Respir Dis. 62:1981;56-64.
44. Kawakami Y., Yamamoto H., Yoshikawa T., Shida A. Chemical and behavioural control of breathing in adult twins. Am Rev Respir Dis. 129:1984;703-707.
45. Kiely D.G., Cargill R.I., Lipworth B.J. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. (comments) Chest. 110(3):1996;698-703.
46. King S.J., Booyse F.M., Lin P.H., Traylor M., Narkates A.J., Oparil S. Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis. Am J Physiol. 256(6, Pt 1):1989;C1231-C1238.
47. Knowles M.R., Carson J.L., Collier A.M., Gatzy J.T., Boucher R.C. Measurement of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis. 124:1981;484-490.
48. Lepori M., Hummler E., Feihl F., Sartori C., Nicoed P., Rossier B. Amiloride sensitive sodium transport dysfunction augments susceptibility to hypoxia-induced lung edema. (abstract) FASEB J. 12:1998;A328.
49. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 270(22):1995;13333-13340.
50. Mairbaurl H., Weyman J., Mohrlein A., Swenson E.R., Maggiorini M., Gibbs J.S., Barsch P. Nasal epithelium potential difference at high altitude (4559 m): evidence for secretion. Am J Respir Crit Care Med. 167(6):2003;862-867.
51. Matsuzawa Y., Fujimoto K., Kobayashi T., Namushi N.R., Harada K., Kohno H., Fukushima M., Kusama S. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol. 66(3):1989;1152-1157.
52. Milledge J.S., Catley D.M. Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization. Clin Sci. 67(4):1984;453-456.
53. Milledge J.S., Catley D.M., Williams E.S., Withey W.R., Minty B.D. Effect of prolonged exercise at altitude on the renin-angiotensin system. J Appl Physiol. 2:1983;413-418.
54. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Byrnes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., Humphries S.E. Human gene for physical performance. (letter) Nature. 393(6682):1998;221-222.
55. Morganti A., Guissani M., Sala C., Gazzano G., Marana I., Pierini A., Savoia N.T., Ghio F., Cogo A., Zanchetti A. Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects. J Hypertens. 13(8):1995;859-865.
56. Morrell N.W., Morris K.G., Stenmark K.R. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol (Heart Circ Physiol 38). 269:1995;H1186-H1194.
57. Morrell N.W., Sarybaev A.S., Alikhan A., Mirrakhimov M.M., Aldashev A.A. Ace genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet. 353:1999;814.
58. Myerson S., Hemingway H., Budget R., Martin J., Humphries S., Montgomery H. Human angiotensin I converting enzyme gene and endurance performance. J Appl Physiol. 87(4):1999;1313-1316.
59. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
60. Palmer L.A., Semenza G.L., Stoler M.H., Johns R.A. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol Lung Cell Mol Physiol. 274(2):1998;L212-L219.
61. Patel S., Woods D.R., MacLeod N., Brown A., Patel K.R., Montgomery H.E., Peacock A.J. ACE genotype and the ventilatory response to exertional hypoxia. Eur Respir J. 22:2003;755-760.
62. Paton J.F.R., Kasparov S. Differential effects of angiotensin II on cardiorespiratory reflexes mediated by nucleus tractus solitarii - a microinjection study in the rat. J Physiol (Lond). 521(1):1999;227-238.
63. Peacock A.J. High altitude pulmonary oedema: who gets it and why? Eur Respir J. 8:1995;1819-1821.
64. Peacock A.J., Matthews A. Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease. Respir Med. 86:1992;21-26.
65. Penazola D., Sime F. Circulatory dynamics during high altitude pulmonary edema. Am J Cardiol. 23:1969;369-378.
66. Pugh C.W., Tan C.C., Jones R.W., Ratcliff P.J. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoetin gene. Proc Natl Acad Sci USA. 88:1991;10553-10557.
67. Quinlan T.R., Li D., Laubach V.E., Shesely E.G., Zhou N., Johns R.A. eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol. 279:2000;L641-L650.
68. Redline S., Leitner J., Arnold J., Tishler P.V., Altose M.D. Ventilatory control abnormalities in familial sleep apnoea. Am J Respir Crit Care Med. 156(1):1997;155-160.
69. Rigat B., Hubert C., Alhenc-Gelas F., Cambien G., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86(4):1990;1343-1346.
70. Roy S.B., Guleria J.S., Khanna P.K., Manchanda J.N., Pande J.N., Subba P.S. Haemodynamic studies in high altitude pulmonary oedema. Br Heart J. 31:1969;52-58.
71. Sakuma T., Okaniwa G., Nakada T., Nishimura T., Fujimura S., Matthay M.A. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med. 150:1994;305-310.
72. Sartori C., Lepori M., Maggiorini M., Allemann Y., Nicod P., Scherrrer U. Impairment of amiloride-sensitive sodium transport in individuals susceptible to high altitude pulmonary edema. (abstract) FASEB J. 12:1998;A231.
73. Sartori C., Vollenweider L., Loffler B.M., Delabays A., Nicod P., Bartsch P. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation. 99(20):1999;2665-2668.
74. Sartori C., Allemann Y., Trueb L., Lepori M., Maggiorini M., Nicod P., Scherrer U. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr. 130:2000;385-389.
75. Sartori C., Allemann Y., Duplain H., Lepori M., Egli M., Lipp E., Hutter D., Turini P., Hugli O., Cook S., Nicod P., Scherrer U. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 346(21):2002;1631- 1636.
76. Scherrer U., Vollenweider L., Delabays A., Savcic M., Eichenberger E., Kleger G.R., Fikrle A., Ballmer P.E., Nicod P., Bartsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med. 334:1996;624-629.
77. Schoene R.B., Hackett P.H., Henderson W.R., Sage E.H., Chow M., Roach R.C., Mills W.J., Martin T.R. High-altitude pulmonary edema: characteristics of lung lavage fluid. JAMA. 256(1):1986;63-69.
78. Schuster S.J., Badiavas E.V., Costa-Giomi P., Weinmann R., Erslev A.J., Caro J. Stimulation of erythropoetin gene transcription during hypoxia and cobalt exposure. Blood. 73:1989;13-16.
79. Semenza G.L., Nejfect M.K., Chi S.M., Antonarakis S.E. Hypoxia-induced nuclear factors bind to an enhancer element located 3′ to the human erythropoetin gene. Proc Natl Acad Sci USA. 88:1991;5680-5684.
80. Silva M., Grillot D., Benito A., Richard C., Nunez G., Ferdenandez-Luna J.L. Erythropoetin can promote erythroid progenitor survival by repressing apoptosis through bcl-xl and bcl-2. Blood. 88:1996;1576-1582.
81. Steudel W., Scherrer-Crosbie M., Bloch K.D., Weimann J., Huang P.L., Jones R.C., Picard M.H., Zapol W.M. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest. 101(11):1998;2468-2477.
82. Stroka D.M., Burkhardt T., Desbaillets I., Wenger R.H., Neil D.A., Bauer C., Gassmann M., Candinas D. HIF-1 is expressed in normoxic tissue and displays an organ specific regulation under systemic hypoxia. FASEB J. 13:2001, Nov 15;2445-2453.
83. Swenson E.R., Mongovin S., Sibbs S., Maggiorini M., Greve I., Mairbaurl H. Stress failure in high altitude pulmonary edema (HAPE). (abstract) Am J Respir Crit Care Med. 161(3):2000;A418.
84. Vachiery J.L., McDonagh T., Moraine J.J., Berre J., Naeije R., Dargie H., Peacock A.J. Doppler assessment of hypoxic pulmonary vasoconstriction and susceptibility to high altitude pulmonary oedema. Thorax. 50(1):1995;22-27.
85. Wang G., Semenza G. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem. 268(29):1993;21513- 21518.
86. Weil J.V., Byrne-Quinn E., Sodal I.E., Friesen W.P., Underhill B., Filley G.F., Grover R.F. Hypoxic ventilatory drive in normal man. J Clin Invest. 49:1970;1061-1072.
87. Welsh D.J., Scott P., Plevin R., Wadsworth R., Peacock A.J. Hypoxia enhances cellular proliferation and inositol 1,4,5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med. 158:1998;1757-1762.
88. 2 regulated gene expression. FASEB J. 10:2002;1151-1162.
89. Woods D.R., Humphries S.E., Montgomery H.E. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab. 11(10):2000;416-420.
90. Woods D.R., Pollard A.J., Collier D.J., Jamshidi Y., Vassiliou V., Hawe E., Humphries S.E., Montgomery H.E. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med. 166:2002;362-366.
91. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1 activator protein-1, GATA-2 and p300/CBP. J Biol Chem. 276(16):2001;12645-12653.
92. Yanagisawa M., Kurihara K., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
93. Yoshimoto S., Ishizaki Y., Sasaki T., Murota S.I. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke. 22:1991;378-383.